02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

104 CEFOTAXIME<br />

Reactions<br />

Skin<br />

Erythema multiforme<br />

(1990): Todd PA+, <strong>Drug</strong>s 40, 608<br />

(1986): Green ST+, Postgrad Med J 62, 415<br />

Exanthems<br />

(1990): Todd PA+, <strong>Drug</strong>s 40, 608<br />

(1984): Smith CR+, AnnInternMed101, 469 (3.4%)<br />

(1983): Carmine AA+, <strong>Drug</strong>s 25, 223 (2%)<br />

Pruritus (2.4%)<br />

(1993): Newton ER+, J Antimicrob Chemother 32 Suppl B, 195<br />

(1990): Todd PA+, <strong>Drug</strong>s 40, 608<br />

(1983): Carmine AA+, <strong>Drug</strong>s 25, 223 (2%)<br />

Rash (sic) (2.4%)<br />

(2005): Mazzeo F+, Pharmacol Res 51(3), 269<br />

(1993): Newton ER+, J Antimicrob Chemother 32 Suppl B, 195<br />

(1982): LeFrock JL+, Clin Ther 5, 19<br />

Stevens–Johnson syndrome<br />

(2003): Liberopoulos EN+, Ann Pharmacother 37(6), 812<br />

Toxic epidermal necrolysis<br />

(2002): Paquet P+, Crit Care Med 30(11), 2580<br />

Urticaria (2.4%)<br />

Mucosal<br />

Vaginitis (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!